Epidemiological and Clinical Characteristics and Risk Factors for Death of Patients with Avian Influenza A H7N9 Virus Infection from Jiangsu Province, Eastern China
Hong Ji(Jiangsu Provincial Center for Disease Control and Prevention), Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Mao Huang(Nanjing Medical University), Wei Zhao, Xia Ling(Hunan University), Yefei Zhu, Shan-Hui Chen(Nanjing Municipal Center for Disease Control And Prevention), Gu-yu Shen(Wuxi People's Hospital), Gen-lin Yang(Wuxi People's Hospital), Ying Xu(University of Science and Technology of China), Yu Xia(Wenzhou Medical University), Ke Xu(Qilu Hospital of Shandong University), Ying-qiu Wu(Soochow University), Yangting Xu(Hebei Provincial Center for Disease Control and Prevention), Cai-ling Gu(Soochow University), Changjun Bao(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Huiyan Yu(Jiangsu Provincial Center for Disease Control and Prevention), Xian Qi(Peking University), Liling Chen(Taiwan Centers for Disease Control), Guoxiang Xie(Centers for Disease Control and Prevention), Quan Cao(Jiangsu Province Hospital), Fenyang Tang(Jiangsu Provincial Center for Disease Control and Prevention), Danjiang Dong(Nanjing Drum Tower Hospital), Jing Ai(University of California, Los Angeles), Qin Gu(Shanghai Jiao Tong University)
Cited by 65
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655